VVT Medical’s ScleroSafe Approved in South Korea for Varicose Vein Treatment – Endovascular Today
April 25, 2024—V.V.T. Med Ltd. (VVT Medical) announced that the company’s ScleroSafe platform was approved by the Ministry of Food
April 25, 2024—V.V.T. Med Ltd. (VVT Medical) announced that the company’s ScleroSafe platform was approved by the Ministry of Food
Join ACC’s Health Equity Task Force and Health Equity, Diversity, and Inclusion (HEDI) team for the next installment of the ACC Health Equity Webinar Series,…
BACKGROUND: The optimal approach to implementing telemedicine hypertension management in the United States is unknown. METHODS: We examined telemedicine hypertension management versus the effect of…
2024 Perfusion Conference | #PerfCon2024 The Denton A. Cooley Auditorium | The Texas Heart Institute | Houston, Texas The Texas Heart Institute 2024 Perfusion Conference…
A 62-year-old women presented with severe MR and recurrent heart failure episodes. Initial data suggest the procedure was a success.
Echocardiography is a vital first-line imaging tool for the diagnosis and management of many cardiovascular diseases. Its availability and low cost have encouraged widespread use…
The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.
BACKGROUND: While tricuspid annular plane systolic excursion (TAPSE) captures the predominant longitudinal motion of the right ventricle (RV), it does not account for ventricular morphology…
Several surgeons told TCTMD they’re highly critical of the trend, saying it’s time for an RCT of TAVI vs SAVR in those below age 65.
At the Forefront of Cardiothoracic Surgery, AATS members have a proven record of distinction within the specialty and have made significant contributions to the care…